Literature DB >> 7590869

Identification and characterization of a major tolerogenic T-cell epitope of type II collagen that suppresses arthritis in B10.RIII mice.

H Miyahara1, L K Myers, E F Rosloniec, D D Brand, J M Seyer, J M Stuart, A H Kang.   

Abstract

Tolerization of B10.RIII mice (H-2r) with intravenously injected type II collagen (CII) renders the animals resistant to induction of collagen-induced arthritis (CIA). In order to clarify H-2r-restricted T-cell responses that modulate CIA, we have analysed the T-cell proliferative response of B10.RIII mice against cyanogen bromide (CB) peptides of CII, and detected the strongest response to alpha 1(II)-CB10 (CII 552-897). A panel of chemically synthesized overlapping peptide homologues was used to deduce the minimum structure of this determinant which was found to be CII 610-618. A 15-residue synthetic peptide flanking this region, CII 607-621, was found to effectively suppress arthritis when administered as a tolerogen. Collectively, these data identify the structural component within alpha 1(II)-CB10 which is capable of inducing tolerance in B10.RIII mice. A similar approach to the treatment of autoimmune arthritis, involving the institution of self-tolerance, has potential applicability to human rheumatoid arthritis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7590869      PMCID: PMC1383817     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  24 in total

1.  Neonatal T-cell tolerance to minimal immunogenic peptides is caused by clonal inactivation.

Authors:  G Gammon; K Dunn; N Shastri; A Oki; S Wilbur; E E Sercarz
Journal:  Nature       Date:  1986 Jan 30-Feb 5       Impact factor: 49.962

2.  Peptide-specific antibodies identify the alpha 2 chain as the proteoglycan subunit of type IX collagen.

Authors:  H Konomi; J M Seyer; Y Ninomiya; B R Olsen
Journal:  J Biol Chem       Date:  1986-05-25       Impact factor: 5.157

3.  Tolerance induction by a poorly arthritogenic collagen II can prevent collagen-induced arthritis.

Authors:  R F van Vollenhoven; C Nagler-Anderson; A Soriano; G W Siskind; G J Thorbecke
Journal:  Cell Immunol       Date:  1988-08       Impact factor: 4.868

4.  Chemistry of antibody binding to a protein.

Authors:  H M Geysen; J A Tainer; S J Rodda; T J Mason; H Alexander; E D Getzoff; R A Lerner
Journal:  Science       Date:  1987-03-06       Impact factor: 47.728

5.  Type II collagen-induced arthritis in mice. II. Passive transfer and suppression by intravenous injection of anti-type II collagen antibody or free native type II collagen.

Authors:  P H Wooley; H S Luthra; C J Krco; J M Stuart; C S David
Journal:  Arthritis Rheum       Date:  1984-09

6.  Type II collagen-induced arthritis in mice. IV. Variations in immunogenetic regulation provide evidence for multiple arthritogenic epitopes on the collagen molecule.

Authors:  P H Wooley; H S Luthra; M M Griffiths; J M Stuart; A Huse; C S David
Journal:  J Immunol       Date:  1985-10       Impact factor: 5.422

7.  Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen.

Authors:  C Nagler-Anderson; L A Bober; M E Robinson; G W Siskind; G J Thorbecke
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

8.  Immunisation against heterologous type II collagen induces arthritis in mice.

Authors:  J S Courtenay; M J Dallman; A D Dayan; A Martin; B Mosedale
Journal:  Nature       Date:  1980-02-14       Impact factor: 49.962

9.  Adoptive transfer of suppression of arthritis in the mouse model of collagen-induced arthritis. Evidence for a type II collagen-specific suppressor T cell.

Authors:  T F Kresina; R W Moskowitz
Journal:  J Clin Invest       Date:  1985-06       Impact factor: 14.808

10.  Collagen-induced arthritis in rats. Evaluation of early immunologic events.

Authors:  J M Stuart; M A Cremer; A H Kang; A S Townes
Journal:  Arthritis Rheum       Date:  1979-12
View more
  4 in total

1.  B cell-deficient mice do not develop type II collagen-induced arthritis (CIA).

Authors:  L Svensson; J Jirholt; R Holmdahl; L Jansson
Journal:  Clin Exp Immunol       Date:  1998-03       Impact factor: 4.330

2.  Molecular characterization of an arthritogenic collagen peptide interacting with I-Ar.

Authors:  Yoshihiko Sakurai; Bo Tang; Edward F Rosloniec; John M Stuart; Andrew H Kang; Linda K Myers
Journal:  Immunology       Date:  2006-01       Impact factor: 7.397

3.  Pathogenesis of collagen-induced arthritis: modulation of disease by arthritogenic T-cell epitope location.

Authors:  Bo Tang; David D Brand; Zhijun Ma; John M Stuart; Linda K Myers; Andrew H Kang
Journal:  Immunology       Date:  2004-11       Impact factor: 7.397

4.  Resistance to development of collagen-induced arthritis in C57BL/6 mice is due to a defect in secondary, but not in primary, immune response.

Authors:  Meng Pan; Insoo Kang; Joe Craft; Zhinan Yin
Journal:  J Clin Immunol       Date:  2004-09       Impact factor: 8.317

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.